Enzymes and probiotics manufacturer Advanced Enzyme Technologies (NSE:ADVENZYMES, BOM:540025) has received board approval to incorporate a wholly-owned subsidiary in the nutrition and wellness space, according to a Tuesday filing to the Indian stock exchanges.
The proposed new entity will be formed to carry on the business of sales and distribution of the parent company's range of products.
The company will subscribe to up to 50,000 equity shares at a face value of 10 rupees per equity share in the proposed arm.
Advanced Enzyme's shares were down nearly 3% in recent trade.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。